- Bergqvist D, Benoni G, Bjorgell O, Fredin H, Hedlundh U, Nicolas S, Nilsson P, Nylander G. Low-molecular weight heparin as prophylaxis against venous thromhoembolism after total hip replacement. N Engl J Med 1996; 335: 696-700.
- Dahl O E. Thromboprophylaxis in hip arthroplasty. New frontiers and future strategy. Acta Orthop Scand 1998; 69: 339-42.
- Dahl O E, Andreasen G, Aspelin T, Muller C, Mathiesen P, Nyhus S, Abdelnoor M, Solhaug J H, Arnesen H. Prolonged thromboprophylaxis following hip replacement surgery. Thromb Haemost 1997; 1: 26-31.
- Lawton R L, Money B F. The use of heparin in patients in whom a pulmonary embolism is suspected after total hip arthroplasty. J Bone Joint Surg (Am) 1999; 81: 1063-71.
- Majkowski R S, Bannister G C, Miles A W. The effect of bleeding on the cement-bone interface. An experimental study. Clin Orthop 1994; 229: 293-7.
- Murray D W, Britton A R, Bulstrode C J. Thromboprophylaxis and death after total hip replacement. J Bone Joint Surg (Br) 1996; 76: 863-70.
- Patterson B M, Marchand R, Ranawat C. Complications of heparin therapy after total joint arthroplasty. J Bone Joint Surg (Am) 1989; 71: 1130-4.
- Planes A, Voshelle N. Darmon J Y, Fagola M, Bellaud M, Huet Y. Risk of deep venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind comparison of enoxaparin versus placebo. Lancet 1996; 348: 224-8.
Acta Orthopaedica Scandinavica
Volume 71, 2000 - Issue 2